TargetCancer Foundation
Research Services • 
Cambridge, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 955 Massachusetts Ave., #343, Cambridge, MA 02139, US |
| Phone number | +1264510094 |
| Website | |
| NAICS | 5417 |
| SIC | 839 |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
Key Contact at TargetCancer Foundation
Samantha Sullivan
Associate Director of Programs and Community Engagement
TargetCancer Foundation Email Formats
TargetCancer Foundation uses 2 email formats. The most common is {first initial} (e.g., j@targetcancerfoundation.org), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@targetcancerfoundation.org | 66.7% |
{first name} | john@targetcancerfoundation.org | 33.3% |
About TargetCancer Foundation
TargetCancer Foundation promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer Foundation directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients. TargetCancer Foundation was founded by Paul Poth in 2009 after his diagnosis with cholangiocarcinoma at age 38. Because his cancer was rare, no treatments existed for it, and very little research was being carried out. Paul passed away in August 2009, but TargetCancer Foundation continues his effort to ensure that others diagnosed with rare cancers will have real treatment options — and a chance to live. By granting seed money to critical research projects that would not otherwise be supported at their initial stages, TargetCancer Foundation supports young, courageous scientists who are committed to finding effective new therapies for rare cancers, and ultimately, all cancers. Since being founded, TargetCancer Foundation has provided over $250,000 in grant funding supporting innovative, high impact research into cholangiocarcinoma and esophageal cancer. In addition, TargetCancer Foundation has funded a fellowship supporting the studies of Harvard Medical School students, and also supported next generation research at the Center for Molecular Therapeutics at Massachusetts General Hospital.
TargetCancer Foundation revenue & valuation
| Annual revenue | $4,627,542 |
| Revenue per employee | $926,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $14,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
TargetCancer Foundation has never raised funding before.
France
Bahrain
Frequently asked questions
4.8
40,000 users
